University of Leiden

Patent Applications and Registrations

Patent applications and USPTO patent grants for University of Leiden.The latest application filed is for "system and method for presenting large dna molecules for analysis".

Company Profile

1.8.4

University of Leiden - Leiden IL NL
University of Leiden - AA Leiden NL
University of Leiden - NL NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
System and Method for En Masse Patterning of Molecule Structures App 20220288589 - Schwartz; David Charles ; et al.	2022-09-15
System And Method For Presenting Large Dna Molecules For Analysis App 20220291166 - Schwartz; David C. ; et al.	2022-09-15
System and method for en masse patterning of molecule structures Grant 11,213,825 - Schwartz , et al. January 4, 2	2022-01-04
System and Method for En Masse Patterning of Molecule Structures App 20200078789 - Schwartz; David Charles ; et al.	2020-03-12
System And Method For Presenting Large Dna Molecules For Analysis App 20150075984 - Schwartz; David C. ; et al.	2015-03-19
Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof Grant 8,853,187 - Zanetti , et al. October 7, 2	2014-10-07
Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof Grant 7,560,490 - Zanetti , et al. July 14, 2	2009-07-14
Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 molecules Grant 6,682,731 - Townsend , et al. January 27, 2	2004-01-27
Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid Grant 6,605,603 - Roldan , et al. August 12, 2	2003-08-12
Bone mass anabolic composition comprising olpadronate Grant 5,885,973 - Papapoulos , et al. March 23, 1	1999-03-23
Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof Grant 5,554,724 - Melief , et al. September 10, 1	1996-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.